参考文献

　　[1] Towbin JA， Bowles NE. The failing heart. Nature， 2002， 415: 227-233

　　[2] Towbin JA， Bowles NE. The failure heart. Nature， 2002， 415: 227-233

　　[3] Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation， 2005， 112: 3547-3553

　　[4] Nabel EG， Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med， 2012， 366: 54-63

　　[5] Lloyd-Jones D， Adams R， Carnethon M， De Simone G， Ferguson TB， Flegal K， Ford E， Furie K， Go A， Greenlund K， Haase N， Hailpern S， Ho M， Howard V， Kissela B， Kittner S， Lackland D， Lisabeth L， Marelli A， McDermott M， Meigs J， Mozaffarian D， Nichol G， O’Donnell C， Roger V， Rosamond W， Sacco R， Sorlie P， Stafford R， Steinberger J， Thom T， Wasserthiel-Smoller S， Wong N， Wylie-Rosett J， Hong Y. Heart disease and stroke statistics--2009 update: A report from the american heart association statistics committee and stroke statistics subcommittee. Circulation， 2009，119: 480-486

　　[6] Liehn EA， Postea O， Curaj A， Marx N. Repair after myocardial infarction， between fantasy and reality: The role of? chemokines. J Am Coll Cardiol， 2011， 58: 2357-2362

　　[7] Wen Z， Zheng S， Zhou C， Wang J， Wang T. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med， 2010

　　[8] Banas A， Teratani T， Yamamoto Y， Tokuhara M， Takeshita F， Quinn G， Okochi H， Ochiya T. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology， 2007， 46: 219-228

　　[9] Strauer BE， Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: From the methodological origin to clinical practice. J Am Coll Cardiol， 2011， 58: 1095- 1104

　　[10] Perin EC， Silva GV， Zheng Y， Gahremanpour A， Canales J， Patel D， Fernandes MR， Keller LH， Quan X， Coulter SA， Moore WH， Herlihy JP， Willerson JT. Randomized， double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. American heart journal， 2012， 163: 415-421， 421 e411

　　[11] Chamberlain G， Fox J， Ashton B， Middleton J. Concise review: Mesenchymal stem cells: Their phenotype， differentiation capacity， immunological features， and potential for homing. Stem Cells， 2007， 25: 2739-2749

　　[12] Choi YH， Kurtz A， Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther， 2011， 22: 3-17

　　[13] Lee M， Lill M， Makkar R. Stem cell transplantation in myocardial infarction. REVIEWS IN CARDIOVASCULAR MEDICINE， 2004， 5: 82-98

　　[14] Chen L， Tredget EE， Wu PY， Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One， 2008， 3: e1886

　　[15] Lian Q， Lye E， Suan Yeo K， Khia Way Tan E， Salto-Tellez M， Liu TM， Palanisamy N， El Oakley RM， Lee EH， Lim B， Lim SK. Derivation of clinically compliant mscs from cd105+， cd24- differentiated human escs. Stem Cells， 2007， 25: 425-436

　　[16] Hida N， Nishiyama N， Miyoshi S， Kira S， Segawa K， Uyama T， Mori T， Miyado K， Ikegami Y， Cui C， Kiyono T， Kyo S， Shimizu T， Okano T， Sakamoto M， Ogawa S， Umezawa A. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells， 2008， 26:1695-1704

　　[17] Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration. American journal of cardiovascular disease， 2012， 2: 58-67

　　[18] Tang XL， Rokosh G， Sanganalmath SK， Yuan F， Sato H， Mu J， Dai S， Li C， Chen N， Peng Y， Dawn B， Hunt G， Leri A， Kajstura J， Tiwari S， Shirk G， Anversa P， Bolli R. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation， 2010， 121: 293-305

　　[19] Mohsin S， Khan M， Toko H， Bailey B， Cottage CT， Wallach K， Nag D， Lee A， Siddiqi S， Lan F， Fischer KM， Gude N， Quijada P， Avitabile D， Truffa S， Collins B， Dembitsky W， Wu JC， Sussman MA. Human cardiac progenitor cells engineered with pim-i kinase enhance myocardial repair. J Am Coll Cardiol， 2012

　　[20] Bolli R， Chugh AR， D’Amario D， Loughran JH， Stoddard MF， Ikram S， Beache GM， Wagner SG， Leri A， Hosoda T， Sanada F， Elmore JB， Goichberg P， Cappetta D， Solankhi NK， Fahsah I， Rokosh DG， Slaughter MS， Kajstura J， Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): Initial results of a randomised phase 1 trial. Lancet， 2011， 378: 1847-1857

　　[21] Makkar RR， Smith RR， Cheng K， Malliaras K， Thomson LE， Berman D， Czer LS， Marban L， Mendizabal A， Johnston PV， Russell SD， Schuleri KH， Lardo AC， Gerstenblith G， Marban E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (caduceus): A prospective， randomised phase 1 trial. Lancet， 2012， 379: 895-904

　　[22] Evans MJ， Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature， 1981， 292: 154-156

　　[23] Thomson JA， Itskovitz-Eldor J， Shapiro SS， Waknitz MA， Swiergiel JJ， Marshall VS， Jones JM. Embryonic stem cell lines derived from human blastocysts. Science， 1998， 282: 1145-1147

　　[24] Shamblott MJ， Axelman J， Wang S， Bugg EM， Littlefield JW， Donovan PJ， Blumenthal PD， Huggins GR， Gearhart JD. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA， 1998， 95: 13726-13731

　　[25] van Laake LW， Passier R， den Ouden K， Schreurs C， Monshouwer-Kloots J， Ward-van Oostwaard D， van Echteld CJ， Doevendans PA， Mummery CL. Improvement of mouse cardiac function by hesc-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Res， 2009， 3: 106-112

　　[26] Jiang J， Au M， Lu K， Eshpeter A， Korbutt G， Fisk G， Majumdar AS. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells， 2007， 25: 1940-1953

　　[27] Cai J， Zhao Y， Liu Y， Ye F， Song Z， Qin H， Meng S， Chen Y， Zhou R， Song X， Guo Y， Ding M， Deng H. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology， 2007， 45: 1229-1239

　　[28] Cowan CA， Klimanskaya I， McMahon J， Atienza J， Witmyer J， Zucker JP， Wang S， Morton CC， McMahon AP， Powers D， Melton DA. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med， 2004， 350: 1353-1356

　　[29] Kaupisch A， Kennedy L， Stelmanis V， Tye B， Kane NM， Mountford JC， Courtney A， Baker AH. Derivation of vascular endothelial cells from human embryonic stem cells under gmp-compliant conditions: Towards clinical studies in ischaemic disease. Journal of cardiovascular translational research， 2012

　　[30] Cheung C， Sinha S. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation. Journal of molecular and cellular cardiology， 2011， 51: 651-664

　　[31] Zhang Q， Jiang J， Han P， Yuan Q， Zhang J， Zhang X， Xu Y， Cao H， Meng Q， Chen L， Tian T， Wang X， Li P， Hescheler J， Ji G， Ma Y. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell research， 2011， 21: 579-587

　　[32] Takahashi K， Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell， 2006， 126: 663-676

　　[33] Wernig M， Meissner A， Foreman R， Brambrink T， Ku M， Hochedlinger K， Bernstein BE， Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent es-cell-like state. Nature， 2007， 448: 318-324

　　[34] Okita K， Nakagawa M， Hyenjong H， Ichisaka T， Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science (New York， N.Y.)， 2008， 322: 949-953

　　[35] Carpenter L， Carr C， Yang CT， Stuckey DJ， Clarke K， Watt SM. Efficient differentiation of human induced pluripotent stem cells generates cardiac cells that provide protection following myocardial infarction in the rat. Stem cells and development， 2012， 21: 977-986

　　[36] Zwi-Dantsis L， Huber I， Habib M， Winterstern A， Gepstein A， Arbel G， Gepstein L. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients. European heart journal， May 22， 2012